Last reviewed: July 2, 2026

Last updated: July 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works as a once-weekly injectable medication that helps regulate appetite and blood sugar levels through GLP-1 receptor activation. Understanding the proper dosing frequency is essential for achieving consistent results in your weight management journey. PlexusDx provides licensed compounded semaglutide injections designed to fit your individual needs and budget.

Understanding Weekly Semaglutide Injection Schedules

Semaglutide is administered as a subcutaneous injection one time each week, typically on the same day to establish a consistent routine. This once-weekly dosing pattern allows the medication to work continuously throughout the seven-day cycle, maintaining steady levels of GLP-1 receptor stimulation. Patients inject just under the skin in the abdomen, thigh, or upper arm, making home administration straightforward after initial training. The weekly schedule differs significantly from daily oral medications, reducing the burden of remembering multiple daily doses.

Clinical trials demonstrate that weekly semaglutide dosing produces sustained appetite suppression and metabolic benefits over a full seven-day period. Most patients begin with a lower starting dose and gradually increase every four weeks until reaching their target maintenance dose. This gradual titration approach minimizes gastrointestinal adjustment and allows your body to adapt to the medication's effects. PlexusDx supports this standard escalation protocol while keeping your monthly cost flat regardless of dose level.

Dose Escalation: How Your Treatment Progresses

Your semaglutide dose typically starts at 0.25 mg once weekly and increases by 0.25 mg every four weeks until reaching your target dose, which may range from 0.5 mg to 2.4 mg weekly. This stepped approach, called titration, gives your gastrointestinal system time to adjust and helps identify the minimum effective dose for your body. Most patients experience noticeable appetite reduction within the first two weeks, though the full benefit develops as doses increase. Your dose may need to go up—your price won't, because PlexusDx charges one flat monthly rate for compounded semaglutide regardless of your maintenance dose.

The titration schedule is flexible based on tolerability and clinical response. Some patients progress through all dose increases over 16 weeks, while others may remain at an intermediate dose if they achieve their weight management goals. Your PlexusDx clinical team reviews your progress and adjusts the schedule if needed to balance efficacy with comfort. Dose changes occur monthly but your investment remains constant at $149 per month for semaglutide injection.

Factors That Influence Your Dosing Frequency and Response

Individual genetic predispositions significantly influence how quickly semaglutide takes effect and which dose proves most effective for your body. Variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), and FTO gene (rs9939609) affect receptor sensitivity and metabolic pathway activation. PlexusDx's Precision Peptide Genetic Test identifies these peptide-pathway variants across 14 metabolic pathways, revealing your unique response potential to semaglutide therapy. Understanding your genetic profile helps your clinician optimize dosing strategy from the start, potentially reducing trial-and-error adjustments.

Liver and kidney function, medication interactions, and baseline appetite regulation also shape how frequently you need dose increases and whether you remain on semaglutide long-term. Patients with certain metabolic conditions may benefit from slower titration schedules to minimize side effects, while others progress more rapidly to higher maintenance doses. Body composition, activity level, and concurrent dietary changes interact with semaglutide's effects, meaning your ideal dose may differ from another patient's despite similar starting points. PlexusDx evaluates these individual factors during initial consultation to establish a personalized treatment timeline.

Oral vs. Injectable Semaglutide: Dosing Frequency Comparison

While injectable semaglutide requires one injection weekly, oral semaglutide tablets are taken daily by mouth and must be dosed on an empty stomach. Oral formulations have lower bioavailability than injections, meaning your body absorbs a smaller percentage of the active compound despite taking medication more frequently. Weekly injections deliver consistent medication levels that remain stable throughout seven days, whereas daily oral doses create variable peaks and troughs in medication concentration. PlexusDx offers both compounded semaglutide injection ($149/mo) and oral semaglutide ($249/mo), allowing you to choose the dosing approach that fits your lifestyle and preferences.

Injectable semaglutide typically produces faster and more substantial weight loss compared to oral formulations in head-to-head comparisons, partly due to superior absorption and steady medication levels. Adherence is often easier with a once-weekly injection schedule than remembering daily oral doses, reducing missed-dose complications. If you prefer injections but want a dual-compound approach, PlexusDx also offers GLP-Squared Injection combining semaglutide with tirzepatide starting at $249 per month, providing synergistic appetite suppression with one weekly needle.

Managing Side Effects With Your Weekly Dosing Schedule

Nausea, vomiting, constipation, and loss of appetite often peak 1-2 days after injection and gradually resolve through the week, meaning side effects follow a predictable weekly cycle. Slower dose escalation (extending intervals between increases beyond four weeks) allows more time for symptom adaptation, reducing overall tolerability problems. Dietary adjustments—eating smaller, lower-fat meals in the days following injection—can significantly minimize gastrointestinal symptoms while maintaining weekly medication schedule. Your PlexusDx clinical team provides detailed side-effect management strategies tailored to your response pattern during each titration phase.

Most patients develop good tolerance within 2-4 weeks at each dose level, with side effects diminishing as their body adapts to the weekly medication rhythm. If you experience significant nausea or other concerning symptoms, your clinician can temporarily pause dose escalation or reduce your current dose while maintaining your weekly injection routine. Staying hydrated, eating protein-rich foods, and adjusting meal timing relative to injection day help optimize comfort during titration. These evidence-based strategies work best when coordinated with PlexusDx's clinical support, available throughout your treatment course.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many times per week do I inject semaglutide?

Semaglutide is injected exactly one time per week, typically on the same day each week to establish consistency. You can choose any day that works for your schedule, as long as you maintain a regular seven-day interval between injections. PlexusDx patients select their injection day during initial setup and receive reminders to stay on schedule.

What does clinical evidence show about weekly semaglutide effectiveness?

Randomized controlled trials demonstrate that once-weekly semaglutide injections produce average weight loss of 15-22% over 68 weeks at the 2.4 mg maintenance dose, significantly outperforming placebo and many other weight-management therapies. Weekly dosing maintains stable medication levels that continuously suppress appetite and improve metabolic markers. The sustained seven-day drug exposure allows durable effects that daily medications cannot match due to variable absorption patterns.

Will my monthly cost increase as my semaglutide dose goes up?

No. PlexusDx charges one flat rate of $149 per month for compounded semaglutide injection regardless of whether you're on 0.25 mg, 1.0 mg, or 2.4 mg weekly—your dose may need to go up, your price won't. This transparent pricing eliminates surprise costs as you progress through your personalized titration schedule, available across all 50 states without insurance or membership requirements.

Is once-weekly semaglutide safe for long-term use?

Weekly semaglutide has demonstrated safety in clinical trials lasting up to two years, with monitored outcomes for pancreatitis, gallbladder disease, and thyroid concerns showing no increased risk in the general population. Individual contraindications exist (personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2), so PlexusDx screens all patients during consultation. Most patients tolerate indefinite weekly semaglutide therapy well once titrated to their effective maintenance dose, though some choose to pause or discontinue after reaching weight goals.

How does the Precision Peptide Genetic Test help with my dosing schedule?

PlexusDx's Precision Peptide Genetic Test ($99 add-on after month one) identifies your unique variants in GLP1R, GIPR, FTO, and MC4R genes across 14 metabolic pathways, predicting how quickly you'll respond to weekly semaglutide and which maintenance dose may work best. This genetic insight allows your clinician to personalize your titration pace and target dose from the start, potentially reducing unnecessary dose increases or side-effect struggles during your first weeks of treatment.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

learn